Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Private labeler receives FDA clearance for acetaminophen, aspirin and caffeine tablets (ANDA 75-794) July 12. Product is first approved generic version of Bristol-Myers Squibb's Excedrin Migraine, which lost marketing exclusivity Jan. 14. Perrigo says it will not launch store brand equivalent until Spring 2002, however, as it focuses on shipping products planned before quality control problems hampered launches last year (1see item, p. 5)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.